• ↑
  • UTMCAP TMT - Stock Pick

UTMCAP TMT - Stock Pick - Tempus AI $TEM

• Overview
  • Healthcare tech company
  • Specializing in AI and precision medicine
  • They want to build the largest library of scientific data to make this data useful for physicians, research purposes, etc.
  • $\begin{array}{cc}\underset{―}{\text{Metric}}& \underset{―}{\text{Value}}\\ \text{Market Cap}& \mathrm{\$}12.18\text{B}\\ \frac{\text{P}}{E}& -57.86\\ \text{Revenue (TTM)}& \mathrm{\$}1.11B\\ \text{Earnings (TTM)}& -\mathrm{\$}203.88\text{M}\\ \text{12-Month Stock Price Target}& \mathrm{\$}78.83\end{array}$
• Products
  • Genomics
    • Diagnostics for molecular data, this data feeds into other products provided.
  • Data Services
    • Anonymized clinical and molecular data to be provided to biotech companies.
  • Algos
    • Algorithmic diagnostic tools and clinical decision support software
    • Uses machine learning to identity care gaps for oncology and cardiology patients
    • Also a platform to clinicians to order tests and review results
    • Integrated is an AI assistant that can retrieve patient info and clinical trials.
• Monetization
  • Creating value from its dataset for other companies as well as for the clinics using their platform as well.
  • Makes money from genomic sequencing services and their data licensing to other companies.
  • This isn't a users first, profit later company. They're currently monetizing their assets yet are still growing.
  • $85\mathrm{\%}$ revenue growth in 2025Q3.
• Strategy
  • AstraZeneca
    • $\mathrm{\$}200\text{ million}$ in data licensingto AstaZeneca.
  • Boehringer Ingelheim
    • Collab to advance their cancer pipeline.
  • Northwestern University
    • They'll use the Algos platform for alzhimer's research.
  • Genialis
    • Partnership to develop RNA based cancer diagnostics.
• Regulation Risks
  • New regulations are being developed as this is a very critical area, you're dealing with training AI models and dealing with patient healthcare data.
  • They would have to abide by current regulations like HIPAA and such.
• Competitors
  • Diagnotics, Genomics companies:
    • Genomic health
    • Revvity
  • Healthcare AI and Data:
    • PathAI
    • Prognos Health
    • Doximity
• Sources:
  • https://www.tempus.com/
  • https://www.cnbc.com/2021/05/25/tempus-disruptor-50.html
  • https://axial.substack.com/p/tempus-ai
  • https://www.bbae.com/blog/tempus-ai-tem-a-deep-dive/
  • https://seekingalpha.com/article/4844202-tempus-ai-opportunity-to-build-position
  • https://craft.co/tempus/competitors